Spots Global Cancer Trial Database for Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
Official Title: Analysis of the Expression of a Specific Set of Genes and Tumor Antigens in Patients With Non-small Cell Lung Cancer or Melanoma
Study ID: NCT00685750
Conditions
Interventions
Study Description
Brief Summary: This study intends to analyze the expression of specific sets of markers in tumor samples and in serum from patients with Non-Small Cell lung Cancer (NSCLC) or Stage III or IV melanoma. The data obtained in this study will be used to guide future development of immunotherapies for melanoma or NSCLC patients. Moreover, the analyses will contribute to definition of markers potentially predictive of clinical response to specific anticancer therapies.
Detailed Description: This protocol posting has been updated due to a protocol amendment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, Park Ridge, Illinois, United States
GSK Investigational Site, Saint Louis, Missouri, United States
GSK Investigational Site, Murray, Utah, United States
GSK Investigational Site, Dijon, , France
GSK Investigational Site, Lille, , France
GSK Investigational Site, Marseille Cedex 5, , France
GSK Investigational Site, Marseille, , France
GSK Investigational Site, Montpellier, , France
GSK Investigational Site, Nantes, , France
GSK Investigational Site, Paris, , France
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany
GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, Germany
GSK Investigational Site, Regensburg, Bayern, Germany
GSK Investigational Site, Wuerzburg, Bayern, Germany
GSK Investigational Site, Greifswald, Mecklenburg-Vorpommern, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Ostercappeln, Niedersachsen, Germany
GSK Investigational Site, Hemer, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Grosshansdorf, Schleswig-Holstein, Germany
GSK Investigational Site, Kiel, Schleswig-Holstein, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Siena, Toscana, Italy
GSK Investigational Site, Padova, Veneto, Italy
GSK Investigational Site, Göteborg, , Sweden
GSK Investigational Site, Lund, , Sweden
GSK Investigational Site, Stockholm, , Sweden
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
